Which are the causes of Barth Syndrome?

Barth Syndrome is a rare genetic disorder caused by mutations in the TAZ gene, which leads to a deficiency of the enzyme tafazzin. This deficiency disrupts the remodeling of cardiolipin, a vital fat molecule in the inner mitochondrial membrane, effectively impairing the cell's ability to produce energy.

What causes Barth Syndrome at the genetic level?

Barth Syndrome is caused by pathogenic variants in the TAZ gene located on the X chromosome. This gene provides instructions for making the protein tafazzin. In individuals with Barth Syndrome, the mitochondria—the "power plants" of the cell—cannot properly remodel cardiolipin. Think of cardiolipin as the "insulation" on the electrical wiring of a cell; when it is defective, the cell’s energy production becomes inefficient, which is particularly devastating for high-energy organs like the heart and skeletal muscles.

Is Barth Syndrome hereditary?

Yes, Barth Syndrome is an X-linked recessive condition. This means that in most cases, the mutation is passed from a mother who is a carrier to her son. Because males have only one X chromosome, they do not have a backup copy of the TAZ gene to compensate for the mutation, leading to the clinical presentation of Barth Syndrome. Females with one mutated copy typically remain asymptomatic carriers.

Are there environmental or external triggers?

Barth Syndrome is strictly a genetic condition. There are no known environmental triggers, dietary factors, or infectious agents that cause the disease. Research into the etiology of Barth Syndrome focuses on the following metabolic consequences:

• Cardiolipin deficiency: The structural instability of mitochondrial membranes.


• Energy failure: Inability of heart and muscle cells to meet metabolic demands.


• Neutropenia: A chronic reduction in white blood cells linked to the same mitochondrial dysfunction.

What is the status of current research?

While the genetic cause of Barth Syndrome is well-understood, researchers are actively investigating how specific TAZ mutations correlate with disease severity. Current studies are exploring gene replacement therapies and small-molecule interventions designed to bypass or correct the cardiolipin remodeling defect.

Next steps

• Consult a metabolic geneticist for definitive diagnostic testing or family counseling.


• Connect with the Barth Syndrome community on DiseaseMaps.org to share experiences with other families.


• Review clinical trial opportunities through the Barth Syndrome Foundation to stay informed on emerging research.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Barth Syndrome


• Orphanet: TAZ-related disorder


• Online Mendelian Inheritance in Man (OMIM): #302060


• Barth Syndrome Foundation: Research and Clinical Information